S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Perceptive Advisors/Q3 2022

Perceptive Advisors

Period: Q3 2022 Β· Filed: 2022-11-14
View on SEC EDGAR β†—
AUM
$3.45B
Total portfolio value
Positions
116
Reported securities
Top Holding
FOLD
8.3% $285.8M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
FOLDAMICUS THERAPEUTICS INC$285.8M8.29%β€”β€”
8.3%
MRTXMIRATI THERAPEUTICS INC$194.5M5.64%β€”β€”
5.6%
CERECEREVEL THERAPEUTICS HLDNG I$184.0M5.34%β€”β€”
5.3%
GBTGLOBAL BLOOD THERAPEUTICS IN$158.2M4.59%β€”β€”
4.6%
AMLXAMYLYX PHARMACEUTICALS INC$154.0M4.47%$28.15$18.27-35.1%
4.5%
LIANYLIANBIO$115.1M3.34%$0.00$0.12
3.3%
CINCCINCOR PHARMA INC$108.5M3.15%β€”β€”
3.1%
BLUBELLUS HEALTH INC NEW$108.2M3.14%β€”β€”
3.1%
CRNXCRINETICS PHARMACEUTICALS IN$104.5M3.03%$19.64$42.23+115.0%
3.0%
SWTXSPRINGWORKS THERAPEUTICS INC$99.0M2.87%β€”β€”
2.9%
IOVAIOVANCE BIOTHERAPEUTICS INC$98.2M2.85%$9.58$4.31-55.0%
2.9%
RLMDRELMADA THERAPEUTICS INC$88.2M2.56%$37.02$6.28-83.0%
2.6%
RXDXPROMETHEUS BIOSCIENCES INC$86.7M2.51%β€”β€”
2.5%
XENEXENON PHARMACEUTICALS INC$76.6M2.22%$36.10$60.96+68.9%
2.2%
ALDXALDEYRA THERAPEUTICS INC$60.6M1.76%$5.34$2.27-57.5%
1.8%
MGTXMEIRAGTX HLDGS PLC$58.6M1.70%$8.41$13.92+65.5%
1.7%
INBXINHIBRX INC$51.8M1.50%β€”$97.58
1.5%
VRNAVERONA PHARMA PLC$51.6M1.50%β€”β€”
1.5%
COGTCOGENT BIOSCIENCES INC$47.9M1.39%$14.92$38.69+159.3%
1.4%
ACLXARCELLX INC$46.3M1.34%$18.77β€”
1.3%
TRAVERE THERAPEUTICS INC$46.0M1.33%β€”β€”
1.3%
LYRAXXXXLYRA THERAPEUTICS INC$45.8M1.33%β€”β€”
1.3%
ALBOALBIREO PHARMA INC$45.7M1.33%β€”β€”
1.3%
VERUXXXXVERU INC$44.9M1.30%β€”β€”
1.3%
RLAYRELAY THERAPEUTICS INC$43.5M1.26%$22.37$18.65-16.6%
1.3%
SGENSEAGEN INC$43.3M1.26%β€”β€”
1.3%
RAPTRAPT THERAPEUTICS INC$41.2M1.20%β€”β€”
1.2%
VBIVXXXXVBI VACCINES INC CDA$37.2M1.08%β€”β€”
1.1%
TMCITREACE MED CONCEPTS INC$35.4M1.03%$22.07$4.21-80.9%
1.0%
NUVLNUVALENT INC$32.2M0.93%$19.44$123.73+536.5%
0.9%

Quarter-on-Quarter Activity

Q3 2022 vs. Q2 2022

New Positions (8)

TickerIssuerNotional
SRPTSAREPTA THERAPEUTICS INC$28.0M
EWEDWARDS LIFESCIENCES CORP$27.3M
CTKBCYTEK BIOSCIENCES INC$19.0M
RCUSARCUS BIOSCIENCES INC$17.4M
AKROAKERO THERAPEUTICS INC$14.6M
PRTAPROTHENA CORP PLC$13.9M
AXGNAXOGEN INC$11.3M
LRMRLARIMAR THERAPEUTICS INC$9.2M

Exited Positions (8)

TickerIssuerNotional
LLYLILLY ELI & CO$32.4M
ALNYALNYLAM PHARMACEUTICALS INC$25.2M
DAWNDAY ONE BIOPHARMACEUTICALS I$9.9M
PRVAPRIVIA HEALTH GROUP INC$8.0M
XBISPDR SER TR$7.4M
NUVBNUVATION BIO INC$5.7M
MGNXMACROGENICS INC$3.6M
FLNACASSAVA SCIENCES INC$2.8M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
RLMDRELMADA THERAPEUTICS INC$85.9M+1864.1%-83.0%
ACLXARCELLX INC$25.6M+115.9%
BMRNBIOMARIN PHARMACEUTICAL INC$13.6M+86.9%
BLUBELLUS HEALTH INC NEW$57.1M+85.2%
VRNAVERONA PHARMA PLC$39.4M+73.1%
TMCITREACE MED CONCEPTS INC$21.9M+70.2%-80.9%
AMLXAMYLYX PHARMACEUTICALS INC$85.8M+54.6%-35.1%
INBXINHIBRX INC$30.1M+50.8%

Trimmed (8)

TickerIssuerNotionalShares Ξ”
ICVXICOSAVAX INC$-5.7M-91.0%
TVTXTRAVERE THERAPEUTICS INC$-11.6M-84.1%
NBIXNEUROCRINE BIOSCIENCES INC$-28.2M-74.9%
PRCTPROCEPT BIOROBOTICS CORP$-13.6M-64.8%
RCKTROCKET PHARMACEUTICALS INC$-8.1M-57.2%
CCXICHEMOCENTRYX INC$-1.0M-56.4%
CHRSCOHERUS BIOSCIENCES INC$-10.4M-54.3%
PNTPOINT BIOPHARMA GLOBAL INC$-3.5M-53.4%
← Back to Hedge Funds